STOCKWATCH
·
Hospital
Quarterly Updates10 Feb 2026, 06:08 pm

Asarfi Hospital Ltd Reports 40% YoY Revenue Growth in Q3 FY26 with Margin Expansion

AI Summary

Asarfi Hospital Ltd, a leading Dhanbad-based healthcare provider, has reported a strong financial performance for the quarter and nine months ended December 31, 2025. The company's revenue for Q3 FY26 rose by 40% YoY to INR 46 Cr, with EBITDA margin at 22% and PAT margin at 12%. The growth was driven by higher patient volumes, improved ARPOB, and improved case mix across both IPD and OPD units. The super-specialty unit and the cancer unit reported strong growth in high-acuity segments, including Cardiology and Neurosciences in the Super-Specialty unit and Head & Neck and Haemato Oncology in the Cancer unit.

Key Highlights

  • Q3'FY26 revenue rose 40% YoY to INR 46 Cr
  • EBITDA margin at 22% and PAT margin at 12%
  • Higher patient volumes, improved ARPOB, and improved case mix
  • Strong growth in high-acuity segments in both IPD and OPD units
  • Super-specialty unit and cancer unit reported robust growth
ASARFI
Hospital
Asarfi Hospital Ltd

Price Impact